Video Experimental Relacionado
Updated: Mar 1, 2026

07:39
Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
Published on: July 26, 2022
4.3K
Intervenciones avanzadas, farmacológicas y complementarias para afecciones de dolor orofacial crónico o recurrente:
Rocco Salvatore Calabrò1, Andrea Calderone2, Lilla Bonanno1
1IRCCS Centro Neurolesi Bonino-Pulejo, S.S. 113 Via Palermo, C.da Casazza, 98124, Messina, Italy.
The journal of headache and pain
|February 27, 2026
Resumen
La fotobiomodulación/terapia láser de baja intensidad (PBM/LLLT) ofrece alivio del dolor a corto plazo para el síndrome de ardor bucal (SAB). Sin embargo, la efectividad a largo plazo y la transportabilidad requieren una mayor investigación debido a intervalos de predicción inciertos y datos limitados.
Área de la Ciencia:
- Orofacial Pain Management
- Evidence Synthesis
- Interventional Therapies
Sus antecedentes:
- Chronic orofacial pain (OP) management increasingly uses advanced technologies and complementary interventions.
- Comparative evidence for these interventions is fragmented across diagnoses, modalities, and outcomes.
- Systematic review and meta-analysis are needed to consolidate fragmented evidence.
Objetivo del estudio:
- To systematically map evidence for advanced and complementary interventions for chronic orofacial pain (OP).
- To conduct selective meta-analyses to estimate intervention effects and certainty of evidence.
- To identify research gaps and inform future clinical practice and trial design.
Principales métodos:
- Systematic evidence map with selective meta-analyses (PROSPERO CRD420251270501) following PRISMA 2020 guidelines.
- Searched six databases for randomized and non-randomized studies in adults with TMD, BMS, TN, and other OP phenotypes.
- Extracted data on pain intensity, disability, function, quality of life, and adverse events; assessed risk of bias and certainty with GRADE.
Principales resultados:
- Included 130 studies (n=6879 participants). Low risk of bias and consistent reporting of outcomes were uncommon.; Photobiomodulation/low-level laser therapy (PBM/LLLT) showed short-term pain reduction in BMS (SMD -0.81), but with moderate certainty and a null-crossing prediction interval.; Evidence for other BMS interventions, TMD, TN, and digital therapeutics was sparse, inconsistent, or of low/very low certainty, with inconsistent adverse event reporting.
Conclusiones:
- PBM/LLLT demonstrates the clearest short-term analgesic signal for BMS, though its transportability is uncertain.
- Future research should standardize outcomes, extend follow-up, and transparently report harms for diagnosis-stratified care.
- More high-quality evidence is needed for effective and safe management of various chronic orofacial pain conditions.
Palabras clave:
síndrome de ardor bucalterapias complementariasmapeo de evidenciaterapia de luz de baja intensidadmetanálisisneuromodulacióndolor orofacialrevisión sistemáticatrastornos de la articulación temporomandibularneuralgia del trigémino
